CNTG
Income statement / Annual
Last year (2023), Centogene N.V.'s total revenue was $48.54 M,
an increase of 2.24% from the previous year.
In 2023, Centogene N.V.'s net income was -$35.53 M.
See Centogene N.V.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$48.54 M |
$47.47 M |
$42.23 M |
$38.45 M |
$48.78 M |
$40.48 M |
$31.69 M |
$27.67 M |
| Cost of Revenue |
$31.29 M
|
$27.55 M
|
$27.67 M
|
$35.29 M
|
$26.01 M
|
$19.94 M
|
$14.94 M
|
$12.86 M
|
| Gross Profit |
$17.25 M
|
$19.92 M
|
$14.57 M
|
$3.17 M
|
$22.78 M
|
$20.54 M
|
$16.75 M
|
$14.81 M
|
| Gross Profit Ratio |
0.36
|
0.42
|
0.34
|
0.08
|
0.47
|
0.51
|
0.53
|
0.54
|
| Research and Development Expenses |
$12.36 M
|
$17.49 M
|
$19.30 M
|
$14.94 M
|
$9.59 M
|
$6.30 M
|
$6.40 M
|
$5.89 M
|
| General & Administrative Expenses |
$29.17 M
|
$29.21 M
|
$43.48 M
|
$37.67 M
|
$23.16 M
|
$18.61 M
|
$9.50 M
|
$8.89 M
|
| Selling & Marketing Expenses |
$12.56 M
|
$9.92 M
|
$9.33 M
|
$7.58 M
|
$9.25 M
|
$7.47 M
|
$5.90 M
|
$5.36 M
|
| Selling, General & Administrative Expenses |
$41.74 M
|
$39.13 M
|
$52.81 M
|
$45.25 M
|
$32.41 M
|
$26.08 M
|
$15.40 M
|
$14.25 M
|
| Other Expenses |
-$7.19 M
|
-$84.00 K
|
$0.00
|
$0.00
|
$109.00 K
|
-$1.24 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$46.91 M
|
$56.53 M
|
$72.98 M
|
$60.18 M
|
$42.11 M
|
$31.30 M
|
$21.40 M
|
$19.96 M
|
| Cost And Expenses |
$78.20 M
|
$84.25 M
|
$98.86 M
|
$144.34 M
|
$68.12 M
|
$51.24 M
|
$36.34 M
|
$32.82 M
|
| Interest Income |
$204.72 K
|
$2.95 K
|
$3.00 K
|
$25.00 K
|
$15.95 K
|
$33.00 K
|
$13.15 K
|
$26.00 K
|
| Interest Expense |
$8.20 M
|
$3.57 M
|
$802.00 K
|
$1.04 M
|
$2.03 M
|
$1.08 M
|
$1.02 M
|
$829.00 K
|
| Depreciation & Amortization |
$7.61 M
|
$10.38 M
|
$19.97 M
|
$15.13 M
|
$6.58 M
|
$5.18 M
|
$3.24 M
|
$2.09 M
|
| EBITDA |
-$19.43 M |
-$24.65 M |
-$36.65 M |
-$43.67 M |
-$12.09 M |
-$5.40 M |
-$1.29 M |
-$2.94 M |
| EBITDA Ratio |
-0.4
|
-0.52
|
-0.87
|
-1.14
|
-0.25
|
-0.13
|
-0.04
|
-0.11
|
| Operating Income Ratio |
-0.61
|
-0.77
|
-1.31
|
-1.4
|
-0.4
|
-0.26
|
-0.14
|
-0.18
|
| Total Other Income/Expenses Net |
-$5.59 M
|
-$1.82 M
|
-$1.93 M
|
-$6.08 M
|
-$1.36 M
|
-$1.04 M
|
-$1.01 M
|
-$741.00 K
|
| Income Before Tax |
-$35.25 M
|
-$38.60 M
|
-$57.42 M
|
-$59.81 M
|
-$20.70 M
|
-$11.65 M
|
-$5.46 M
|
-$5.77 M
|
| Income Before Tax Ratio |
-0.73
|
-0.81
|
-1.36
|
-1.56
|
-0.42
|
-0.29
|
-0.17
|
-0.21
|
| Income Tax Expense |
$287.00 K
|
$107.00 K
|
-$70.00 K
|
$224.00 K
|
$158.00 K
|
-$310.00 K
|
$14.00 K
|
-$408.00 K
|
| Net Income |
-$35.53 M
|
-$31.84 M
|
-$46.25 M
|
-$21.38 M
|
-$20.86 M
|
-$11.34 M
|
-$5.48 M
|
-$5.36 M
|
| Net Income Ratio |
-0.73
|
-0.67
|
-1.09
|
-0.56
|
-0.43
|
-0.28
|
-0.17
|
-0.19
|
| EPS |
-1.27 |
-1.11 |
-2.09 |
-1.02 |
-1.27 |
-0.57 |
-0.28 |
-0.27 |
| EPS Diluted |
-1.26 |
-1.11 |
-2.09 |
-1.02 |
-1.27 |
-0.57 |
-0.28 |
-0.27 |
| Weighted Average Shares Out |
$28.16 M
|
$26.81 M
|
$22.44 M
|
$20.91 M
|
$16.41 M
|
$14.11 M
|
$12.07 M
|
$214.05 K
|
| Weighted Average Shares Out Diluted |
$28.16 M
|
$26.81 M
|
$22.44 M
|
$20.91 M
|
$16.41 M
|
$14.11 M
|
$12.07 M
|
$214.05 K
|
| Link |
|
|
|
|
|
|
|
|
